Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.500
-0.050 (-3.23%)
At close: May 12, 2026, 4:00 PM EDT
1.590
+0.090 (6.00%)
After-hours: May 12, 2026, 7:13 PM EDT
Boundless Bio Employees
Boundless Bio had 28 employees as of December 31, 2025. The number of employees decreased by 36 or -56.25% compared to the previous year.
Employees
28
Change (1Y)
-36
Growth (1Y)
-56.25%
Revenue / Employee
n/a
Profits / Employee
-$1,999,786
Market Cap
33.63M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 28 | -36 | -56.25% |
| Dec 31, 2024 | 64 | -8 | -11.11% |
| Mar 31, 2024 | 72 | 0 | - |
| Dec 31, 2023 | 72 | - | - |
| Sep 30, 2023 | 71 | - | - |
| Jun 30, 2023 | 72 | - | - |
Related Stocks
Employee RankingsBOLD News
- 4 days ago - Boundless Bio reports Q1 EPS (60c), consensus (56c) - TheFly
- 4 days ago - Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire
- 25 days ago - Boundless Bio presents preclinical data for BBI-940 therapy at AACR - TheFly
- 25 days ago - Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting - GlobeNewsWire
- 2 months ago - Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026 - GlobeNewsWire
- 2 months ago - Boundless Bio Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Boundless Bio reports Q4 EPS (58c), consensus (52c) - TheFly
- 2 months ago - Boundless Bio sees cash runway into 2H28 - TheFly